iSpecimen Inc.

NASDAQ: ISPC · Real-Time Price · USD
1.20
0.03 (2.92%)
At close: Aug 15, 2025, 10:00 AM

iSpecimen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.29M 9.93M 10.4M 11.14M
Cost of Revenue
5.3M 4.82M 4.76M 5.25M
Gross Profit
3.99M 5.11M 5.65M 5.89M
Operating Income
-12.73M -11.17M -10.19M -5.93M
Interest Income
44.13K 339.75K 169.34K 11.4K
Pretax Income
-12.5M -11.1M -10.25M -8.96M
Net Income
-12.5M -11.1M -9.04M -10.02M
Selling & General & Admin
12.65M 11.68M 12.37M 9.4M
Research & Development
n/a 3.57M 2.66M 1.84M
Other Expenses
5.7M 1.03M 801.13K 573.91K
Operating Expenses
16.72M 16.28M 15.83M 11.81M
Interest Expense
220.07K 230.78K 238.96K 2.1M
Selling & Marketing Expenses
4.95M 3.96M 3.45M 2.42M
Cost & Expenses
22.02M 21.1M 20.59M 17.06M
Income Tax Expense
n/a n/a -1.21M 1.05M
Shares Outstanding (Basic)
710.85K 452.07K 441.63K 408.62K
Shares Outstanding (Diluted)
710.85K 452.07K 442.21K 408.62K
EPS (Basic)
-17.58 -1.23 -20.47 -24.51
EPS (Diluted)
-17.58 -24.55 -20.44 -24.51
EBITDA
-12.73M -9.1M -8.8M -5.86M
EBIT
-12.67M -10.87M -10.01M -6.86M
Depreciation & Amortization
-56.47K 2.07M 1.21M 1M